Congenital ulcerating hemangioma in a baby with KRAS mutation and cardio-facio-cutaneous syndrome

Clinical Dysmorphology

Volumn 16, Issue 3, 2007, Pages 203-206

  Tang, Ben ^a,c   Reardon, Willie ^b   Black, Graeme C ^a   Kerr, Bronwyn A ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^c NONE   (United Kingdom)

Author keywords

Cardio facio cutaneous syndrome; Ectodermal abnormalities; Hemangioma; KRAS mutation

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN; PROTEIN KRAS; UNCLASSIFIED DRUG;

ARTICLE; CARDIO FACIO CUTANEOUS SYNDROME; CARDIOMYOPATHY; CASE REPORT; CONGENITAL ULCERATING HEMANGIOMA; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION; GENETIC DISORDER; GENETIC HETEROGENEITY; HEART ATRIUM SEPTUM DEFECT; HEMANGIOMA; HUMAN; ICHTHYOSIS; INFANT; PRIORITY JOURNAL; PULMONARY VALVE STENOSIS;

ABNORMALITIES, MULTIPLE; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; FEMALE; HEMANGIOMA; HUMANS; INFANT, NEWBORN; MOLECULAR SEQUENCE DATA; MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; SYNDROME;

EID: 34250011199     PISSN: 09628827     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCD.0b013e328011f974     Document Type: Article

References (16)

1. Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, Tanaka Y, et al. (2005). Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 37:1038-1040.
2. Berg JN, Walter JW, Thisanagayam U, Evans M, Blei F, Waner M, et al. (2001). Evidence for loss of heterozygosity of 5q in sporadic hemangiomas: are somatic mutations involved in hemangioma formation? J Clin Pathol 54: 249-252.
3. Blei F, Walter J, Orlow SJ, Marchuk DA (1998). Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol 134:718-722.
4. Boye E, Yu Y, Paranya G, Mulliken JB, Olsen BR, Bischoff J (2001). Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 107:745-752.
5. Kavamura MI, Peres CA, Alchorne MM, Brunoni D (2002). CFC Index for the diagnosis of cardio-facio-cutaneous syndrome. Am J Med Genet 112:12-16.
6. Kerr B, Mucchielli ML, Sigaudy S, Fabre M, Saunier P, Voelckel MA, et al. (2003). Is the locus for Costello syndrome on 11p? J Med Genet 40:469-471.
7. Kerr B, Delrue MA, Sigaudy S, Perveen R, Marche M, Burgelin I, et al. (2006). Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. J Med Genet 43:401-405.
8. Niihori T, Aoki Y, Narumi Y, Neri G, Cave H, Verloes A, et al. (2006). Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat Genet 38:294-296.
9. Powell J (1999). Update on hemangiomas and vascular malformations. Curr Opin Pediatr 11:457.
10. Reynolds JF, Neri G, Herrmann JP, Blumberg B, Coldwell JG, Miles PV, Opitz JM (1986). New multiple congenital anomalies/mental retardation syndrome with cardio-facio-cutaneous involvement:the CFC syndrome. Am J Med Genet 25:413-427.
11. Rodriguez-Viciana P, Tetsu O, TidymanWE, Estep AL, Conger BA, Cruz MS, et al. (2006). Germline mutations in genes within the MAPK pathway cause cardiofacio-cutaneous syndrome. Science 311:1287-1290.
12. Schubbert S, Zenker M, Rowe SL, Boll S, Klein C, Bollag G, et al. (2006). Germline KRAS mutations cause Noonan syndrome. Nat Genet 38: 331-336.
13. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. (2001). Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465-468.
14. Vikkula M, Boon LM, Mulliken JB, Olsen BR (1998). Molecular basis of vascular anomalies. Trends Cardiovasc Med 8:281-292.
15. Walter JW, Blei F, Anderson JL, Orlow SJ, Speer MC, Marchuk DA (1999). Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet 82:77-83.
16. Weiss G, Confino Y, Shemer A, Trau H (2004). Cutaneous manifestations in the cardiofaciocutaneous syndrome, a variant of the classical Noonan syndrome. Report of a case and review of the literature. J Eur Acad Dermatol Venereol 18:324-327.